liraglutide glp 1 analogue Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update GLP-1 Analogue - Semaglutide/Liraglutide #internalmedicine

The bloating is often worse in the evening

[DOI] [PMC free article] [PubMed] [Google Scholar] Yaqub T, Tikhonova IG, Lttig J, Magnan R, Laval M, Escrieut C, Boulgue C, Hewage C, Fourmy D

These questions signal a shift in focus

Limitations of Use: Wegovy should not be used in combination with other semaglutide-containing products or any other GLP-1 receptor agonist Who should not use Wegovy

Kidney Int 2022;102:97489

The 2026 EASO pharmacotherapy update formalised this evidence by ranking tirzepatide above semaglutide for obesity management, while simultaneously supporting semaglutide as the better-documented agent for liver fibrosis improvement in metabolic dysfunction-associated steatohepatitis (MASH), based on more mature phase 3 ESSENCE trial data [1]